Do We Now Have the Tools to Meaningfully Improve Outcomes for People With Schizophrenia?
- 1 October 2025
- journal article
- Published by American Psychiatric Association Publishing in FOCUS
- Vol. 23 (4) , 373-374
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Thirteen-fold variation between states in clozapine prescriptions to United States Medicaid patientsSchizophrenia Research, 2023
- Preliminary point prevalence of Cognitive Behavioral Therapy for psychosis (CBTp) training in the U.S. and CanadaPsychosis, 2022
- Long-acting injectable versus oral antipsychotics for the maintenance treatment of schizophrenia: a systematic review and comparative meta-analysis of randomised, cohort, and pre–post studiesThe Lancet Psychiatry, 2021
- Effect of Long-Acting Injectable Antipsychotics vs Usual Care on Time to First Hospitalization in Early-Phase SchizophreniaJAMA Psychiatry, 2020
- New Tools for Implementing Evidence-Based Care for Serious Mental IllnessFOCUS, 2020
- Progress in Schizophrenia Research and TreatmentFOCUS, 2020